Source – Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study[/caption]
National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
Pregabalin add-on for drug-resistant focal epilepsy
This evidence summary presents the best available evidence regarding pregabalin add-on for drug-resistant focal epilepsy.1
Introduction
Approximately 3–3.5% of Australians will experience epilepsy at some point...
Marea O’Donnell extended interview
As a pharmacist who cares about people, any extra involvement of having pharmacists in aged care is going to be good. It’s going to...
PSA NT/SA Branch’s vaccine advocacy work
The PSA SA/NT Branch is fighting for pharmacists to be able to administer more vaccines. Read more about it here.
New ECP Director to focus on the future
WA-based hospital pharmacist Lauren Burton has been appointed as the new Early Career Pharmacist (ECP) Director of PSA, effective from 1 July 2018.
PSA...
Is Australia’s scope of care lagging behind?
Nations around the globe used to look to Australia for examples of bold and innovative pharmacy funding projects. But many of our overseas peers...
Digital transformation with My Health Record
Pharmacists should be actively contributing to patients' My Health Record (MHR) in order to unlock the full potential of digital transformation, said Dr Kenneth...
